EIT Digital Innovation Activity 'ki elements' Showcases its First Prototype: DELTA

EIT DigitalThe EIT Digital Innovation Activity 'ki elements' showcases its first prototype called DELTA in Nice at the Institut Claude Pompidou on Innovation Alzheimer Open Day.

In the beginning of 2017, EIT Digital launched ELEMENT, a new Innovation Activity to facilitate faster, earlier diagnosis and intervention for cognitive decline.

In June 2017, the Innovation Activity ELEMENT took a new step forward with the official launch of its start-up: ki elements.

CEO Jan Alexandersson (also Activity Lead) of ELEMENT explains: "We are very proud and happy to showcase our first prototype called Delta during the Innovation Alzheimer Day in collaboration with Association Innovation Alzheimer at the Institut Claude Pompidou in Nice. Our prototype is an iPad app for psychometric testing based on language as diagnosis support for professionals working in psychiatry, neuropsychology and speech pathology."

How the Delta app works:

  • Delta records and saves speech data and synchronises it with your HIS (Hospital Information System). This allows you to easily re-listen to patients and empowers your professional decisions.
  • Delta automatically transcribes answers from cognitive speech tests to keep your attention free for the most important thing: your work with the patient.
  • Delta leverages AI and computational linguistics to extract and analyse powerful scientific metrics from patients' answers.
  • Delta gives you comprehensive insight by visualising the extracted metrics. Combined with population cut-off values, this visualisation helps to enrich your professional impression
  • Delta compiles your test analysis, visualisations and your interpretation/diagnosis into a digital report formatted to your clinic's guidelines.

Jan Alexandersson continues: "We are hoping this prototype demo will help us find our potential first customers, collect feedback about our value proposition. We are also working on CE certification of our product and looking to extending our portfolio towards the German market by the end of 2018. For 2017, our focus is on the French market."

The mission of ki elements is to provide health professionals with AI-empowered tools as key elements to excel in their profession.

ELEMENT has implemented a first alpha version of the product targeting dementia diagnosis support for clinicians based on speech analysis.

Dementia is a cognitive disorder, mainly caused by neurodegenerative diseases, such as Alzheimer's disease but also strokes, which leads to a loss of autonomy and is associated with significant decrease in quality of life. In 2015 around the world, there were 9.9 million new cases of dementia: one every 3 seconds*. This number is expected to double every 20 years and reach 68% of the worldwide population in 2050 (mostly in low-medium income countries and due, in part, to fewer births and a growing elderly population).

Partners involved in the Innovation Activity are:

  • DFKI: Activity lead, coordination, mobile and app integration
  • ki elements (sub-grantee of DFKI GmbH): commercialisation of project results
  • Inria: Corpus collection, video analysis and clinical trials
  • University of Edinburgh: Trials and validation of current system for British English
  • Innovation Alzheimer (sub-grantee of INRIA): Clinical partner providing access to dementia patients for French corpus collection and tests. Clinical personnel will be involved.

    * Alzheimer's Disease International

    About EIT Digital
    EIT Digital seeks to generate significant innovations from top European research. As such, we focus our investments on a limited number of innovation areas known as Innovation Action Lines, that we have selected with respect to their European relevance and leadership potential. Each Innovation Action Line comprises a portfolio of activities including:

    • open innovation activities carried out by the EIT Digital Partners and
    • fast-growing technology startups that are ready to scale commercially.

    Our Innovation Activities deliver new products or services, create startups and spinoffs to commercialise outputs from projects and encourage the transfer of technologies for market entry.

  • Most Popular Now

    Unlocking the 10 Year Health Plan

    The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

    Alcidion Grows Top Talent in the UK, wit…

    Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

    AI can Find Cancer Pathologists Miss

    Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

    New Training Year Starts at Siemens Heal…

    In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

    AI, Full Automation could Expand Artific…

    Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

    How AI could Speed the Development of RN…

    Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

    MIT Researchers Use Generative AI to Des…

    With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

    AI Hybrid Strategy Improves Mammogram In…

    A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

    Penn Developed AI Tools and Datasets Hel…

    Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

    Are You Eligible for a Clinical Trial? C…

    A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

    Global Study Reveals How Patients View M…

    How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

    New AI Tool Addresses Accuracy and Fairn…

    A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...